18. Wolff, S.N., G.L. Phillips, and G.P. Herzig, High dose carmustine with autologous bone marrow 
transplant for the adjuvant treatment of high grade gliomas of the central nervous system. Cancer Treat. 
Rep., 1987. 71: p. 183-185. 
19. Moolten, F., Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: 
paradigm for a prospective cancer control strategy. Cancer Res., 1986. 46: p. 5276-5281. 
20. Hasegawa, Y., et a!., Gene transfer of herpes simplex virus type I thymidine kinase gene as a drug 
sensitivity gene into human lung cancer cell lines using retoviral vectors. Am. J. Respir. Cell Mol. Biol., 
1993. 8: p. 655-661. 
21 . Smythe, W.R., et al., Use of Recombinant Adenovirus to Transfer the HSV-Thymidine Kinase Gene 
to Thoracic Neoplasms: An Effective In Vitro Drug Sensitization System. Cancer Res., 1994. 54: 
p. 2055-2059. 
22. Smythe, W.R., et al., Treatment of Experimental Human Mesothelioma Using Adenovirus 
Transfer of the Herpes Simplex-Thymidine Kinase Gene. Cancer Res., 1994. In press. 
23. Caruso, M., et al.. Regression of established macroscopic liver metastases after in situ 
tranduction of a suicide gene. Proc. Natl. Acad. Sci. USA, 1993. 90: p. 7024-7028. 
24. Abe, A., et al., Transduction of a drug-sensitive toxic gene into human leukemia cell lines with a 
novel retroviral vector. Proc. Soc. Exp. Biol. Med., 1993. 203(3): p. 354-359. 
25. Golumbek, P.T., et al., Herpes simplex-1 virus thymidine kinase gene is unable to completely 
eliminate live, nonimmunogenic tumor cell vaccines. Journal of Immunotherapy, 1992. 12: p. 224- 
230. 
26. Myklebust, A.T., A. Godal, and O. Fodstad, Targeted therapy with immunotoxins in a nude rat 
model for leptomeningeal growth of human small cell lung cancer. Cancer Research, 1994. 54: p. 
2146-2150. 
27. Barba, D., et al., Thymidine kinase-mediated killing of rat brain tumors. J. Neurosurg., 1993. 
79: p. 729-735. 
28. Barba, D., et al., Development of anti-tumor immunity following thymidine kinase-mediated 
killing of experimental brain tumors. Proc. Nat'l. Acad. Sci. USA, 1994. 91: p. 43-48-4352. 
29. Culver, K.W., et al., In vivo gene transfer with retroviral vector-producer cells for treatment 
of experimental brain tumors. Science, 1992. 256: p. 1550-1552. 
30. Takamiya, Y., et al., An experimental model of retrovirus gene therapy for malignant brain 
tumors. J. Neurosurg., 1993. 79: p. 104-110. 
31. Takamiya, Y., et al., Gene therapy of malignant brain tumors: a rat glioma line bearing the 
herpes simplex virus type 1-thymidine kinase gene and wild type retrovirus kills other tumor cells. 
Journal of Neuroscience Research, 1992. 33: p. 493-503. 
32. Chen, S.-H., et al., Gene Therapy for brain tumors: Regression of experimental gliomas 
by adenovirus- mediated gene transfer in vivo. 3054-57. Proc Nat Acad Sci, 1994. 91: p. 
3054-57. 
[372] 
Recombinant DNA Research, Volume 20 
